I have decided to coin a new philosophy around the support of people who live with changing cognitive abilities.
This short and not-too-sweet post is an addendum to my guest editorial that was published here in McKnight’s on Friday, July 24th.
“Hello. My name is Richard, and I have dementia, probably of the Alzheimer’s type.” These are the words Dr. Richard Taylor used to open each of his presentations, as he enlightened the world about the lived experience of changing cognitive ability. Richard passed away at his home on July 25th, due to cancer.
In my last post I criticized the Australian Financial Review for its characterization of people living with dementia, and of our aging population in general. Now that the furor over that article has subsided somewhat, it’s time to tackle that deeper concern.
Last week I came across the most irresponsible, ill-informed, and inflammatory bit of writing I have ever seen on the topic of dementia.
I believe our top priority is to build all inclusive communities, both for our aging population in general, as well as those living with changing cognitive abilities of all kinds. Here’s why:
I promised to follow-up with additional blog posts about my experience at the Alzheimer’s Disease International 2015 conference in Perth, Western Australia. Here is a quick post with full video from my plenary session.
People living with various forms of dementia often exhibit certain signs of emotional upset, which may include anger, sadness, fear, frustration, or anxiety. Have any of you ever experienced these feelings? Maybe you too have dementia!
America has a looming public health crisis. And it also happens to be America’s favorite pastime.
Here are a few “tricks of the trade” designed by Big Pharma to make you spend far more money than you need — buyer beware!
One of my favorite principles of “enlightened leadership” is called “Expect the Best” — a principle that is ignored with alarming regularity in long-term care, on both the provider and the regulator sides.
Given the reality that most people are not currently equipped with the knowledge and resources to implement other solutions, there will be times when the use of medication may need to be considered. So here are some guidelines for those along the journey who have not yet created the infrastructure for an anti-psychotic-free environment.
Recently, a friend who works in long-term care wrote to ask if I had any formal guidelines for prescribing antipsychotic drugs to people living with dementia.
Recently, I was interviewed for an article at Chabad.org about tips for including loved ones living with dementia in Chanukah celebrations. With Christmas fast approaching, it seems appropriate to review a few of those tips here for your upcoming family gatherings.
One of the nicest compliments I ever received for my work came in an unexpected way; in fact, I had to think about it for a while to decide if it truly was a compliment.
Thanks to NPR for identifying this ongoing issue, but we need to also broaden the discussion to look at how our society views dementia, how we have chosen to care for our elders, and the systems that regulate and reimburse that care.
I have been advocating that community planners switch to the terms “age-inclusive” and “dementia-inclusive,” as these terms raise the bar by requiring the inclusion of such people in all aspects of community life and planning, rather than simply creating a kind but misguided process of substituted judgment.
We have been graphing the age and dementia distribution for baby boomers for decades, and yet none of our projections have ever extended beyond the year 2050. Why is that?
I recently cautioned in an op-ed that our attempts to reduce antipsychotic drugs among patients with dementia would soon become problematic if we have not also learned how to care differently. And the chickens are starting to come home to roost.
A new study from UCSD demonstrates the potential of self-fulfilling prophecy for those who live in a world with a highly stigmatized view of dementia.